Multiple Sclerosis Resource Centre

Welcome to the Multiple Sclerosis Resource Centre. This website is intended for international healthcare professionals with an interest in Multiple Sclerosis. By clicking the link below you are declaring and confirming that you are a healthcare professional

New video interviews from the AAN Annual Meeting 2015

This year’s annual meeting took place from April 18-25 in Washington DC. We are very happy to provide our readers with some exclusive and interesting video interviews.

Dr. Alastair Compston from Cambridge University (UK) talks about the adverse events of alemtuzumab and the risk management strategies that are in place. Dr. Lloyd Kasper from Geisel School of Medicine at Dartmouth in Hanover (USA) explains how most risk factors for MS are influenced by the gut microbiome. Dr. Emmanuelle Waubant from the University of California, San Francisco (USA) discusses the influence of diet on the pathogenesis and progression of MS. Dr. Fred Lublin from the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai Medical Center (USA) talks about the results of the phase III INFORMS study (fingolimod) which showed an 80% response rate after 1 year of treatment.


About the Editors

  • Prof Timothy Vartanian

    Timothy Vartanian, Professor at the Brain and Mind Research Institute and the Department of Neurology, Weill Cornell Medical College, Cornell...
  • Dr Claire S. Riley

    Claire S. Riley, MD is an assistant attending neurologist and assistant professor of neurology in the Neurological Institute, Columbia University,...

Search this site

Search form


Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Subscribe »

This online Resource Centre has been made possible by a donation from EMD Serono, Inc, a subsidiary of Merck KGaA, Darmstadt, Germany and from Pfizer Inc.

Note that EMD Serono, Inc. and Pfizer Inc have had no editorial control or influence over the content of this Resource Centre. The Resource Centre and all content therein have been subject to an independent editorial review

The Grant for Multiple Sclerosis Innovation
supports promising translational research projects by academic researchers to improve understanding of multiple sclerosis (MS) for the ultimate benefit of patients.  For full information and application details, please click here

Grant submission deadline extended to 2 March 2015.

Journal Editor's choice

Multiple Sclerosis and Related Disorders ; Volume 3, Issue 2

Prof. Gavin Giovannoni

Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis
D.R. Altmann, K. Schmierer, K. Hunter, D.J. Tozer, C.A. Wheeler-Kingshott, A. Coles, D.H. Miller
Multiple Sclerosis and Related Disorders, April 2014, Vol 3 Issue 2.